FAQ/Help |
Calendar |
Search |
Today's Posts |
04-04-2017, 10:18 PM | #11 | ||
|
|||
Member
|
Quote:
As I said, all of the Alzheimer's research has failed to date. Could be that the drugs just don't work in the cell like they do in cerebral fluid ; could be it attacks the wrong protein ; or it could be that the protein aggregation is just a by-product of the disease and not part of the causal sequence. |
||
Reply With Quote |
"Thanks for this!" says: | jeffreyn (04-04-2017) |
06-22-2018, 09:47 PM | #12 | ||
|
|||
Member
|
This recent article from AlzForum gives an update on PRX002 (plus discussion and comments).
α-Synuclein Antibody Appears Safe, Reaches Brain | ALZFORUM |
||
Reply With Quote |
06-23-2018, 09:58 PM | #13 | ||
|
|||
Member
|
This post on the SoPD blog covers the recently-released PRX002 Phase 1b results (and includes a lot of background information).
Prothena: Phase I results published | The Science of Parkinson's |
||
Reply With Quote |
"Thanks for this!" says: | kiwi33 (06-24-2018) |
06-24-2018, 01:45 AM | #14 | |||
|
||||
Grand Magnate
|
Jeffreyn, the more I read from SoPD the more impressed I am.
Your latest link is a good example. It describes some complex ideas from immunology and protein misfolding in a non-technical way which is clear and accurate (my colleagues and I worked in these fields and published quite a few papers on them). I hope that the latest work turns out to be helpful to people with PD.
__________________
Knowledge is power. |
|||
Reply With Quote |
"Thanks for this!" says: | jeffreyn (06-24-2018) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||